Evaluation of recombinant factor VIII (Kogenate®) stability for continuous infusion using a minipump infusion device

Haemophilia

Volumn 4, Issue 6, 1998, Pages 785-789

  Hurst, D ^a,b   Zabor, S ^a   Malianni, D ^a   Miller, D ^a  

^a BAYER CORPORATION   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Infusion; Kogenate; Methods; Recombinant factor VIII; Stability

Indexed keywords

BLOOD CLOTTING FACTOR 8; HEPARIN; POLYETHYLENE; POLYVINYLCHLORIDE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ARTICLE; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG STABILITY; FLUSHING; HEMOSTASIS; MINIPUMP; PRIORITY JOURNAL; TEMPERATURE;

DRUG EVALUATION; DRUG STABILITY; FACTOR VIII; HEMOPHILIA A; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; RECOMBINANT PROTEINS;

EID: 0031797706     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.00204.x     Document Type: Article

References (23)

1. McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor VIII in classic haemophilia. Br J Haematol 1970; 18: 659-67.
2. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
3. Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost 1994; 72: 403-7.
4. Schulman S, Lindstedt M, Alberts KA, Agren PH. Recombinant factor Vila in multiple surgery. Thromb Haemost 1994; 71: 154.
5. Hay CR, Doughty HI, Savidge GF. Continuous infusion VIII for surgery and major bleeding. Blood Coagul Fibrinolysis 1996; 7 Suppl. 1: S15-9.
6. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med 1993; 328: 453-9.
7. Berntorp E. The treatment of haemeophilia, including prophylaxis, constant infusion and DDAVP. Baillieres Clin Haematol 1996; 9: 259-71.
8. Cohen LJ, McWilliams NB, Neuberg R, et al. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Haematol 1995; 50: 269-76.
9. Bech RM. Recombinant factor Vila in joint and muscle bleeding episodes. Haemostasis 1996; 26 Suppl. 1: 135-8.
10. Gordon EM, Mungo R, Goldsmith JC. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII. Am J Pediatr Hematol Oncol 1993; 15: 107-10.
11. Richardson NGB, Miller AL, O'Shaughnessy. Successful treatment of acute subdural haemorrhage with continuous intravenous infusion of factor VIII in a 17 year old with hemophilia A. Haemophilia 1996; 2: 173-6.
12. Goldsmith JC. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII). Blood Coagul Fibrinolysis 1996; 7 Suppl. 1: S3-6.
13. Blatt PM, White GC, McMillan CW, Roberts HR. Treatment of anti-factor VIII antibodies. Thromb Haemost 1977; 38: 514-23.
14. Gordon EM, al-Batniji F, Goldsmith JC. Continuous infusion of monoclonal antibody-purified factor VIII: rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII. Am J Hematol 1994; 45: 142-5.
15. Hathaway WE, Christian MJ, Clarke SL, Hasiba U. Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A. Am J Hematol 1984; 17: 85-8.
16. Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR. The use of continuous infusion of factor concentrates in the treatment of hemophilia. Am J Hematol 1989: 32: 8-13.
17. Morfini M, Messori A, Longo G. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion. Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S11-4.
18. Martinowitz U, Schulman S. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options? Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S27-33.
19. Schulman S, Gitel S, Martinowitz U. Stability of factor VIII concentrates after reconstitution. Am J Hematol 1994; 45: 217-23.
20. Martinowitz U. Stability of factor VIII preparation in continuous infusion. Ann Hematol 1994; 68 (Suppl. 3): S69-71.
21. Martinowitz U, Schulman S. Coagulation factor concentrates by continuous infusion. Transfus Med Rev 1997; 11: 56-63.
22. DiMichele DM, Lasak ME, Miller CH. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion. Am J Hematol 1996; 51: 99-103.
23. Schulman S, Martinowitz U. Design and assessment of clinical trials on continuous infusion. Blood Coagul Fibrinolysis 1996; 7 (Suppl. 1): S7-9.